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Aim: To determine the cost-effectiveness of utilizing point-of-care testing (POCT) on the Abbott 
i-STAT device as a support tool to aid decisions regarding the emergency medical retrievals of 
patients at remote health centers in the Northern Territory (NT) of Australia.
Methods: A decision analytic simulation model–based economic evaluation was conducted 
using data from patients presenting with three common acute conditions (chest pain, chronic 
renal failure due to missed dialysis session(s), and acute diarrhea) at six remote NT health centers 
from July to December 2015. The specific outcomes measured in this study were the number 
of unnecessary emergency medical retrieval prevented through POCT. Cost savings through 
prevented unnecessary medical retrievals for each presentation type were then determined and 
extrapolated to give per annum NT-wide estimates.
Results: POCT prevented 60 unnecessary medical evacuations from a total of 200 patient cases 
meeting the selection criteria (48/147 for chest pain, 10/28 for missed dialysis, and 2/25 for 
acute diarrhea). The associated cost savings were AUD $4,674, $8,034, and $786 per patient 
translating to NT-wide savings of AUD $13.72 million, $6.45 million, and $1.57 million per 
annum (AUD $21.75 million in total) for chest pain, missed dialysis, and acute diarrhea pre-
sentations, respectively.
Conclusion: This study demonstrated that POCT when used to aid decision making for acutely 
ill patients delivered significant cost savings for the NT health care system by preventing unnec-
essary emergency medical retrievals.
Keywords: acute, remote health, primary care, retrieval, acute care, myocardial infarction, 
dialysis, dehydration, indigenous health, pathology testing, medical retrieval, cost-effectiveness
Introduction
The health status of Australians living in rural and remote communities is gener-
ally poorer than that of matched populations living in urban Australia. This trend is 
consistent across both chronic and acute disease presentations.1 Remotely located 
patients requiring urgent medical care are most often transferred through aerial medi-
cal retrieval services to the nearest metropolitan hospital emergency department. The 
decision to evacuate a patient from a remote health facility is made based on the best 
available evidence at the time using clinical interpretation, basic medical equipment, 
and discussion with an on-call medical practitioner often based at a tertiary hospital. 
The lack of medical staff and equipment often necessitates that the patient is evacuated 
so as to err on the side of caution. This is because in the remote Northern Territory 
(NT), if patients are not able to remain in community because of clinical requirements, 
Correspondence: Brooke A Spaeth
Flinders University International Centre 
for Point-of-Care Testing, Level 3 West 
Wing, Sturt Campus, Flinders University, 
Bedford Park, SA 5042, Australia
Tel +61 88 201 7555
Fax +61 88 201 7666
Email brooke.spaeth@flinders.edu.au
Journal name: ClinicoEconomics and Outcomes Research
Article Designation: ORIGINAL RESEARCH
Year: 2018
Volume: 10
Running head verso: Spaeth et al









































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1




they must be evacuated as no overnight clinical services are 
available within these remote health facilities. This may lead 
to unnecessary hospitalizations. The Australian Institute of 
Health and Welfare reported that across 2008–2009, ~8.5% 
of all hospitalizations (30.6/1000 persons) in Australia could 
have been avoided if managed effectively out of hospital.2 
This trend is amplified with increasing remoteness for most 
acute and chronic conditions with the NT having the highest 
rate of avoidable hospitalizations in Australia (47.8/1000 
persons).2
In the NT, the cost of aeromedical evacuations is borne 
by the NT Department of Health, which quotes a cost of 
$141.59 per minute flight time in its Fees and Charges 
Manual.3 For a 1-hour return medical retrieval, this equates 
to a total cost of $8,495 per evacuation. This figure is consis-
tent with published data from rural and remote Queensland 
aeromedical evacuations of $8,520 per 1-hour interhospital 
transfer.4 The cost of medical evacuations via helicopter is 
substantially higher at $16,171 per 1-hour return flight.3 
The CareFlight 2014/15 Annual Report documented a total 
of 2789 emergency evacuations for the Top End of the 
NT (111 [4%] of which were via helicopter),5 based on an 
average 2-hour return flight; this equates to an annual cost 
estimate of $47 million dollars per annum for the Top End 
jurisdiction alone. Rural and remote disadvantage is also 
reflected in poorer standards of general services and health 
infrastructure including pathology services. Point-of-care 
testing (POCT) allows pathology testing to be conducted 
during a patient visit with results immediately available for 
patient care.6 POCT has a particular niche in rural and remote 
communities where access to mainstream laboratory services 
is generally poor, there are long delays in transporting pathol-
ogy samples to laboratories, turnaround time for delivery of 
test results back to the local health service may be slow, and 
patient loss to follow-up is high.7,8 For medical emergencies 
in these sectors, the speed of POCT provides critical practical 
and operational benefits by providing another tool to assist 
in the triage of acutely ill patients. The additional clinical 
information provided by POCT adds valuable data within the 
patient assessment. These extra data reduce the intrinsic risk 
implied by deciding to leave a patient in a community, with 
its lower level of available clinical care. POCT also identifies 
patients at high risk but an absence of clinical signs (eg, a 
patient clinically stable post infarct).
POCT is considered to be generally more expensive than 
traditional laboratory pathology testing as it is not able to 
achieve the same economy of scale.9–11 However, a limited 
number of studies have examined the cost effectiveness of 
POCT in a rural or remote context. One previous study based 
on data from a hospital in rural New Zealand demonstrated 
that POCT improved diagnostic certainty and thereby reduced 
the number of transfers to the major base hospital by 62% 
and increased weekly discharges from seven pre-POCT to 
34 post-POCT, with associated cost savings of NZ$362,138 
per annum.12
Previous studies from our research group have evaluated 
the analytical safety, operational efficiency, and clinical 
effectiveness of the i-STAT (Abbott Point of Care, Princeton, 
NJ, USA) POCT device in the primary care setting in remote 
NT.13–16 The use of the i-STAT device in the remote NT 
includes tests for cardiac troponin I, electrolytes, blood gases, 
urea, creatinine, glucose, ionized calcium, and international 
normalized ratio (INR) with results for each test available 
in 10 minutes or less. The present study from our group is 
the first to provide an economic evaluation of POCT on the 
i-STAT for acute presentations in this setting. Our hypothesis 
is that POCT will prevent unnecessary medical evacuations 
and thereby lead to cost savings. Unnecessary evacuations 
were defined as the number of evacuations that would have 
taken place in the absence of POCT results, that is, based 
solely on clinical interpretation, basic medical equipment, 
and discussion with an on-call off-site medical practitioner. 
This analysis took the form of a model-based probabilistic 
economic evaluation assessing whether POCT leads to costs 
savings through preventing unnecessary medical retrievals 
when compared to usual care.
Methods
Site selection
In Australia’s NT, remote health care is provided through 
primary health care facilities that have limited infrastruc-
ture, resources, and staffing levels, with high rates of staff 
turnover. These remote health facilities are generally located 
many hundreds of kilometers from the nearest major tertiary 
hospital, necessitating air transport as the best (and often 
only) option for acutely ill patients.
Six remote health services in the NT that have access 
to on-site POCT (and were current participants in the NT 
i-STAT POCT Program) were selected to evaluate the clinical 
and cost effectiveness of the management of acute patient 
presentations. The six remote health centers comprised two 
large centers (servicing an indigenous population base of 
between 2000 and 3000 clients), two medium-sized centers 
(~1000 clients), and two small centers (<500 clients). Two 
of the health centers were located in the Central Australian 
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 comprises a mainly desert environment) and four were from 
the Top End of the NT (which comprised the tropical northern 
half of the Territory).
Acute presentations
The economic evaluation in this study focused on three 
common acute presentations observed in the NT: chest pain 
or other symptoms suggestive of acute coronary syndrome 
(ACS) with no obvious ST-elevation on electrocardiogram 
(ECG); symptoms resulting from missed dialysis session(s) 
in the setting of chronic renal failure (CRF); and symptoms 
suggestive of acute dehydration due to diarrhea and/or vomit-
ing. A detailed description of the normal pathways for each 
acute condition and how POCT changes these pathways was 
provided in a separate paper by our research group, which 
outlined the clinical effectiveness of POCT.15 The i-STAT 
tests investigated in this study were troponin I for ruling out 
ACS; potassium and creatinine to measure CRF patient risk; 
and sodium, potassium, and chloride for assessing possible 
acute dehydration.
Adverse events
To determine if patients who remained in the remote com-
munities experienced any adverse events, the electronic case 
notes within the Patient Care Information System (PCIS) 
were examined for each patient 10 days after their initial 
presentation. Adverse events included any secondary acute 
presentation, a medical evacuation, or death.
Ethics registration
Data on the prevalence of the three presentation types in 
patients serviced by the remote health center network of the 
NT Department of Health were sourced from the NT Health 
Data Warehouse (NTHDW), requiring the investigators to 
gain ethics approval for this project from the Menzies School 
of Health Research Ethics Committee (Application Number 
2015-2469, approved September 2015). A data release appli-
cation form for NTHDW was also lodged in November 2015 
and approved on May 20, 2016. A condition of ethics approval 
was that all remote community and individual patient identi-
ties must be kept anonymous.
Development of the economic evaluation 
model
A decision analytic simulation model (DASM) or “Decision 
Tree”17,18 was used to assess whether POCT leads to cost 
savings compared to usual care in the three separate acute 
medical presentations outlined above. A modeling framework 
is ideally suited to demonstrate and explore the importance 
of the inherent uncertainty in the cost-effectiveness ques-
tion.19 In the POCT arm, the decision to medically evacuate 
a patient was made on the basis of on-site i-STAT results 
from the participating remote health centers. In the usual care 
arm, the project’s Chief Clinical Investigator (Senior Rural 
Medical Practitioner in the NT) provided an independent 
clinical judgment on whether each patient would or would 
not have been evacuated to hospital should the results from 
the i-STAT device not have been available at the time of the 
presentation. This decision was based on clinical interpreta-
tion, results of basic medical equipment tests, and review 
of the patient’s electronic record. This process is exactly the 
way clinical decisions about evacuations were made routinely 
prior to POCT being available at all sites, with the Clinical 
Advisor having considerable experience in these decision-
making processes, both before and after the introduction of 
POCT in the NT.
Model structures and inputs
The structures of the DASM for each condition are shown in 
Figure 1. The pathways for the modeled acute presentations 
within the POCT and usual care arms were designed to mirror 
those observed in the general population during the course of 
this study. The pathways were also informed by a review of 
the literature and advice from clinical experts on the research 
team. The model combined estimates of probabilities relating 
to transitions between the models’ health states, resource use/
cost, and the number of evacuations avoided in each arm.
Probabilities providing a quantitative estimate of the like-
lihood that a given event within the clinical pathways would 
occur were obtained from the NT Department of Health PCIS 
and are presented for both POCT and usual care arms (data 
supplied in Table S1).
Resource use and subsequent costs associated with both 
the POCT and usual care arms were estimated to calculate 
mean costs per patient for both arms (Table S2). Total costs 
per patient were estimated by combining resource use data 
and unit costs for these resources (derived from published 
data sets including those from the NTHDW). Total costs per 
patient were calculated as the sum of staff costs (incurred 
when carrying out assessments and tests and undergoing 
training), equipment costs (including costs of the i-STAT 
device), and costs of supplies (eg, consumables such as 
i-STAT cartridges, syringes for blood sampling, gloves, and 
protective equipment). Drug costs (eg, morphine, clopidogrel, 
enoxaparin, calcium resonium, and lactulose) and treatment 
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Figure 1 Decision tree models depicting clinical pathways for “Point-of-Care Testing” compared to “Usual Care” for the three medical presentations.
Notes: (A) Patients with acute chest pain without ST elevation on ECG. (B) Patients with chronic renal failure who missed a dialysis session(s). (C) Patients with acute 
diarrhea and evidence of dehydration. In all models, “#” is 1 – the probability in the branch above; Medical evacuation, individual was medically evacuated; No medical 
evacuation, individual was not medically evacuated. Model A: Usual Care – Chest Pain, usual care arm for individuals with acute chest pain; ProbMedEvac_UsualCare_Chest, 
probability of being evacuated in the usual care arm; POCT – Chest Pain, point of care test arm for individuals with acute chest pain; Single cTnI test, pathway for individuals 
that have a single cardiac troponin I test within the POCT arm; Prob_SinglecTnI_test_Positive, probability of having a positive result from a single cTnI test; cTnI test positive, 
having a positive result from a single cTnI test;  Prob_SinglecTnI_test_Positive, probability of having a positive result from a single cTnI test; cTnI test negative, having a 
negative result from a single cTnI test; ProbMedEvacAfterSingleNegTest, probability of being evacuated following a negative result from a single cTnI test; Repeat cTnI test, 
pathway for individuals that have a repeat cTnI test within the POCT arm; First cTnI test positive; having a positive result from the first of repeat cTnI test; Prob_RepeatcTnI_
test_FirstPositive, probability of having a positive result from the first of repeat cTnI tests; Repeat cTnI test positive, having a positive result on the second cTnI test; 
Prob_RepeatcTnI_test_FirstPositive_SecondPositive, probability of having two positive results from the repeat cTnI tests; Repeat cTnI test negative, having a negative result 
on the second cTnI test; ProbMedEvac_FirstPositive_SecondNegativeTest, probability of being evacuated following a positive and then a negative result from repeat cTnI 
tests; First cTnI test negative, having a negative result from the first of repeat cTnI test; Prob_RepeatcTnI_test_FirstNegative_SecondPositive, probability of having negative 
and then a positive result from the repeat cTnI tests; ProbMedEvac_FirstNegative_SecondNegativeTest, probability of being evacuated following two negative results from 
repeat cTnI tests. Model B: Usual Care – Dialysis, usual care arm for individuals with chronic renal failure who missed a dialysis session(s); ECG changes detected, pathway for 
individuals in whom ECG changes were detected; ProbMedEvac_UsualCare_Dialysis, probability of being evacuated following ECG changes being detected; No ECG changes 
detected, pathway for individuals in whom  no ECG  changes were detected; POCT – Dialysis, point of care test arm for individuals with chronic renal failure who missed a 
dialysis session(s); K+>6.5 mmol/L, pathway for individuals who had a positive potassium assay test result; ProbMedEvac_KplusGreaterThanSixPointFive_Dialysis, probability 
of being evacuated following a positive potassium assay test result; K+<6.5mmol/L, pathway for individuals who had a negative potassium assay test result; ProbMedEvac_
KplusLessThanSixPointFive_Dialysis, probability of being evacuated following a negative potassium assay test result. Model C: Usual Care – diarrhea, usual care arm for 
individuals with acute diarrhea and evidence of dehydration; Rehydration failure,  pathway for individuals who had rehydration failure; ProbMedEvac_UsualCare_Diarrhea, 
probability of having rehydration failure in the usual care arm which is equal to the probability of being evacuated following rehydration failure in this arm; Rehydration 
success,  pathway for individuals who had rehydration success;  POCT – Diarrhea, point of care test arm for individuals with acute diarrhea and evidence of dehydration; Na+/
K+ test, sodium and potassium test used in the POCT arm; ProbMedEvac_UsualCare_Diarrhea, probability of having rehydration failure in the POCT arm which is equal to 
the probability of being evacuated following rehydration failure in this arm.
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ongoing operational costs of conducting i-STAT testing and 
other clinical assessments, and costs of medical evacuations 
also formed part of the total costs. Equipment and training 
costs were annuitized at 5% and based on a conservative 
lifetime of 5 years.20 An annual maintenance cost for equip-
ment of $1,039 was also included in the costing. All resource 
costs used in the model are reported in Australian dollars at 
2017/18 unit prices. The Supplementary materials provide a 
description of the resource use and data estimates split into 
pre-evacuation, evacuation, and prevalence estimates.
Economic evaluation
A patient-level analysis was undertaken from a health sec-
tor (Medicare) cost perspective and the results reported in 
terms of cost savings because of prevention of unnecessary 
medical evacuation. Probabilistic analyses were used in the 
base case and sensitivity analyses based on 100,000 Monte 
Carlo simulations. To facilitate the probabilistic analyses, 
beta distributions were used to model the probability of 
transitions between health states while gamma distributions 
were fitted to all costs.
The availability of estimates on the cost of a medical 
evacuation for a single patient (Table S3) enabled incre-
mental cost savings due to medical evacuations avoided to 
be calculated. These savings were calculated as the average 
weighted round-trip cost of a medical evacuation times the 
number of unnecessary medical evacuations avoided less 
the incremental cost (Table S3). Per patient incremental cost 
savings for each medical presentation were then extrapolated 
to the general NT population through multiplying them 
by the prevalence estimates for each respective medical 
presentation.
Sensitivity analysis for the economic evaluation was 
undertaken to assess uncertainty in the cost savings due to 
avoided medical evacuations by splitting the sample into Top 
End services (n=40 services) cost of per medical evacuation 
or Central Australian services (n=32 services) and applying 
the respective costs of medical evacuations for these services 
(Table S3).
Results
A summary of the economic evaluation results provided in 
Table 1 shows that the mean ± standard error costs per patient 
(presented for the usual care and POCT arms, respectively) 
were $257±1 and $341±1 (acute chest pain), $274±1 and 
$308±1 (missed dialysis), and $204±1 and $306±1 (acute 
diarrhea). The total cost of a round-trip medical evacua-
tion was estimated as $22,560 per patient (data supplied in 
Table S3).
Patients presenting with chest pain 
(without ST elevation on ECG)
Compared to usual care, POCT for patients with acute chest 
pain (POCT – Chest Pain) was more expensive (by $84 per 
patient; 95% confidence interval [CI]: $81–$86) but also 
more effective (prevented 0.2109 unnecessary medical 
evacuations per patient; 95% CI: 0.2106–0.2112, Table 1). 
Adopting the “POCT – Chest Pain” strategy and then spend-
Table 1 Costs, effectiveness, and cost savings based on the number of unnecessary medical evacuations avoided
Strategy Mean (SE) 
cost per 
patient (AU $)
Difference (95% CI) 





(95% CI) in 
effectivenessa
Cost savings 
per patientb – 
NT (AU $)
Cost savings 
per patientb – 
TE (AU $)
Cost savings 
per patientb – 
CA (AU $)
Acute chest pain
 Usual care 257.20 (0.85) 83.76 (81.41–86.12) 0.64613 (0.0012) 0.21090  
(0.21063–0.21117)
4,674.11 5,292.36 3,630.18
 POCT 340.97 (0.85) 0.85703 (0.00010)
Missed dialysis
 Usual care 273.70 (0.77) 34.38 (32.21–36.45) 0.03557 (0.00012) 0.35769 
 (0.35721–0.35817)
8,034.96 9,083.52 6,264.46
 POCT 308.08 (0.61) 0.39326 (0.00031)
Acute diarrhea
 Usual care 204.38 (0.53) 101.58 (99.91–103.25) 0.56059 (0.00034) 0.03934  
(0.03835–0.04033)
785.93 901.26 591.20
 POCT 305.96 (0.59) 0.59993 (0.00030)
Notes: aEffectiveness was measured in terms of the number of unnecessary medical evacuations avoided per patient. bIncremental cost savings per patient associated with 
POCT because of medical evacuations avoided were calculated as the average weighted round-trip cost of a medical evacuation ($21,717 [base case – NT as a whole], $24,539 
[TE], and $16,952 [CA]) times the difference in the number of medical evacuations avoided (ie, incremental effectiveness) less the incremental cost.
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ing $34,097 per 100 patients, as opposed to $25,720 per 100 
patients under the “Usual Care – Chest Pain” strategy, would 
lead to 21 unnecessary medical evacuations being avoided 
(Table 1). Adopting the “POCT – Chest Pain” strategy in 
place of usual care would lead to cost savings (due to unnec-
essary medical evacuations avoided) of $4,674 per patient, 
translating to cost savings of $13.72 million per annum for 
the entire NT population (Table 2) based on an acute chest 
pain prevalence figure estimate of 2,936 for the NT in 2015.
Patients presenting with CRF/missed 
dialysis session(s)
POCT for patients with CRF who missed one or more dialy-
sis sessions (POCT – Missed Dialysis) was more expensive 
(by $34 per patient; 95% CI: $32 to $36) than usual care for 
these patients (Usual Care – Missed Dialysis) but also more 
effective (prevented 0.3577 unnecessary medical evacuations 
per patient; 95% CI: 0.3572–0.3582). Adopting the “POCT – 
Missed Dialysis” strategy and then spending $30,808 per 100 
patients, as opposed to $27,370 per 100 patients under the 
“Usual Care – Missed Dialysis” strategy, would lead to 36 
unnecessary medical evacuations being avoided (Table 1). 
A decision to adopt POCT instead of usual care for patients 
who missed dialysis would lead to cost savings of $8,035 
per patient, translating to cost savings of $6.45 million per 
annum for the entire NT population (Table 2) based on a 
2015 prevalence figure estimate of 803 people that missed 
dialysis in the NT in 2015.
Patients presenting with acute diarrhea
POCT for patients with acute diarrhea (POCT – Diarrhea) was 
more expensive than usual care for these patients (Usual Care 
– Diarrhea) by $102 per patient (95% CI: $100–$103) but also 
more effective (ie, this strategy prevented 0.04 unnecessary 
medical evacuations per patient; 95% CI: 0.0384–0.0403). 
Adopting the “POCT – Diarrhea” strategy and then spend-
ing $30,596 per 100 patients, as opposed to $20,438 per 100 
patients under the “Usual Care – Diarrhea” strategy, would 
lead to four unnecessary medical evacuations being prevented 
(Table 1). Adopting the “POCT – Diarrhea” strategy in place 
of usual care would lead to cost savings of $786 per patient, 
translating to cost savings of $1.57 million per annum for the 
entire NT population (Table 2) based on an acute diarrhea 
prevalence figure estimate of 2,001 for the NT in 2015.
Sensitivity analysis
In the sensitivity analyses, restricting the analysis to just the 
Top End services (n=40; cost per medical evacuation per 
patient=$25,491 as per Table S3) resulted in cost savings of 
$5,292 per patient for acute chest pain, $9,084 per patient 
for missed dialysis, and $901 per patient for acute diarrhea. 
The corresponding overall savings for these Top End services 
Table 2 Total cost savings estimates for the Northern Territory, Top End, and Central Australia

















Chest pain without ST-elevation on 
ECG
$4,674 1621 (6.98) 1315 2936 $22,560 $13.72
 Top End $5,292 1239 (7.55)d 934e 2173 $25,491f $11.50
 Central Australia $3,630 382 (5.62)g 381h 763 $17,610 $2.77
Chronic renal failure with missed 
dialysis session
$8,035 427 (1.84) 352 (1.84) 803 $22,560 $6.45
 Top End $9,084 204 (1.24)d 154 (1.24%)e 358 $25,491f $3.24
 Central Australia $6,264 223 (3.38)g 222 (3.38%)h 445 $17,610 $2.79
Acute diarrhea with symptoms of 
dehydration
$786 1097 (4.73) 906 (4.73%) 2001 $22,560 $1.57
 Top End $901 781 (4.76)d 589(4.76%)e 1370 $25,491f $1.23
 Central Australia $591 316 (4.65)g 315 (4.65%)h 631 $17,610 $0.37
Top End total savings $15.98
Central Australia total savings $5.84
Northern Territory total savings $21.75
Notes: aPCIS prevalence = direct prevalence of each condition obtained from 2015 NT Data Warehouse figures (ie, number of patients with the condition/total number 
of people living in remote communities serviced by Department of Health remote health centers in the NT).21 bEstimated remaining prevalence = % prevalence from Data 
Warehouse figures multiplied by the total number of people living in remote communities serviced by the Aboriginal community–controlled health sector in the NT;21 it 
assumes that % prevalence from Data Warehouse figures is the same for remote communities serviced by the Aboriginal community–controlled health sector. CNT total 
estimated prevalence=sum of a+b. dTop End PCIS population=16402; eTop End NGO population=12372; fMore weight was given to three large sites/centers in the Top 
End as determined by the number of evacuations in this calculation. gCA PCIS population=6794; Total PCIS population=23196. hCA NGO population=6782; Total NGO 
population=19154. NT total remote population=42,350.
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were $11.50 million, $3.24 million, and $1.23 million per 
annum (Table 2). When the analysis focussed on Central 
Australian services (n=32; cost per medical evacuation per 
patient=$17,610 – as per Table S3), cost savings per patient 
were $3,630 (acute chest pain), $6,264 (missed dialysis), 
and $591 (acute diarrhea) leading to corresponding overall 
savings for these services of $2.77 million, $2.79 million, 
and $0.37 million per annum, respectively.
No adverse events were recorded within 10 days of the ini-
tial presentation for patients who remained in the community.
Discussion
A recent international study highlighted the importance of 
conducting setting-specific cost-effectiveness studies for 
POCT and the need for clinicians, policymakers, and indus-
try to address the gaps in knowledge base in this area.22 This 
study is the first in Australia to provide a detailed economic 
evaluation of acute POCT in the remote primary care setting.
Within this setting, POCT was shown to deliver an esti-
mated cost saving of $21.75 million because of prevention of 
unnecessary medical retrievals for the whole NT. In terms of 
clinical presentation, savings were greatest in the “chest pain” 
patient group ($13.72 million) compared to the savings in the 
“missed dialysis” ($6.45 million) and the “acute diarrhea” 
groups ($1.57 million). The differences in costs savings for 
Central Australia ($5.94 million) and Top End ($15.98 mil-
lion) were due to differences in prevalence and total numbers 
of evacuations in these jurisdictions. Although the cost of 
delivering the POCT pathway per patient was slightly higher 
(by $84, $34, and $102, respectively) for the three clinical 
presentations than the usual care pathway, the cost savings in 
prevented evacuations far outweighed this small cost impost.
This research highlights that POCT can produce substantial 
cost savings, which significantly outweigh operational costs, 
through preventing unnecessary medical evacuations when 
used in the rural and remote health care setting, where access 
to timely pathology results is not available. These cost savings 
could be realized by other rural and remote jurisdictions nation-
ally and internationally through adoption of quality-assured 
POCT networks to aid decision making for acute presentations 
with the additional benefit of increasing patient safety.
This study has some limitations. First, this research 
project did not investigate the additional in-hospital costs 
saved through preventing admission to a tertiary hospital. 
The effects of unnecessary medical evacuations on patient/
community (eg, loss of productivity or social or emotional 
wellbeing of Indigenous patients) were also not included in 
this study. However, an Australian report on the economic 
value of pathology found that troponin testing alone reduced 
the number of admissions to metropolitan emergency 
departments resulting in cost savings of ~$166.5 million per 
annum.23 The same report also estimated that troponin test-
ing enabled an early discharge strategy to be safely pursued 
for ~40% of patients with suspected ACS.23 This finding is 
similar to the present study in which 38% of patients pre-
senting with chest pain (and no ST-elevation) did not require 
an evacuation as a result of on-site troponin I testing on the 
i-STAT device. Therefore, including data on admissions 
prevented as well as broader costs and outcomes would most 
likely have made POCT even more cost-effective. Costs 
associated with keeping the patient in a remote health facility 
for monitoring were also not included in this study. These 
costs are, however, estimated to be minimal as no overnight 
stay beds are available in remote health clinics because of 
NT government policy.
Second, the clinical and cost effectiveness of POCT in this 
study was only examined for three common acute presenta-
tion types. A survey of clinical staff indicated that the i-STAT 
was also being used for additional acute presentations such as 
respiratory disorders and sepsis, as well as for the management 
of patients on anticoagulation therapy. The use of the i-STAT for 
these presentations is likely to provide additional clinical and 
cost benefits, which have not been part of this study. It is also 
noteworthy that the cost of administering the entire NT POCT 
Program, operational costs, and the cost of the i-STAT device 
(including servicing and maintenance) were calculated for all 
POCT conducted on the i-STAT device during the study period 
(including for example INR, blood gas, and lactate testing). 
A small percentage of evacuations in the NT are provided by 
helicopter (<5%); this mode of evacuation is extremely costly 
(~$16,167 per hour compared to $8,495 per hour for a fixed-
wing air evacuation) but was not factored into the economic 
evaluation because data on the number of helicopter evacua-
tions were not able to be sourced from the Central Australian 
region; as a result, the total cost savings documented in this 
study may be slightly underestimated. The average per patient 
cost of using the i-STAT was calculated to be $58; however, 
the costs per patient varies depending on the number of patient 
tests performed on the i-STAT (for example, for one of the 
health centers servicing a smaller population in our study, the 
per patient cost of using the i-STAT test was $76.35, whereas 
for one of the larger centers the per patient cost was $31.58).
Finally, some of the sample sizes used in estimating the 
probabilities for the models were small and could, therefore, 
reduce the power of our analyses. Future research should 
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While the focus of this study was to examine the clinical 
and cost effectiveness of POCT for acute presentations, it also 
highlighted a major cultural benefit of POCT. The prevention 
of unnecessary medical retrievals enabled many patients to 
remain in their community, rather than having to suffer the 
social and emotional trauma associated with dislocation from 
their families by having to undergo an evacuation for further 
investigation to a tertiary institution.
Conclusion
Until now, the current literature from metropolitan tertiary set-
tings indicated that, while POCT can generate improved clini-
cal outcomes, it is generally more expensive than traditional 
laboratory pathology testing. However, little information is 
available on the economic effectiveness of POCT in remote 
settings, where POCT has a particular niche in providing 
access to critical pathology results in a timely manner. This 
study demonstrates that POCT can deliver significant cost 
savings (of the order of nearly AUD $22 million per annum) 
for the health care system through ruling out unnecessary and 
expensive emergency medical retrievals in remote Australia.
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